Gelatin/Hyaluronic Acid Scaffold Coupled to CpG and MAGE-A5 as a Treatment against Murine Melanoma

Gelatin/Hyaluronic Acid Scaffold Coupled to CpG and MAGE-A5 as a Treatment against Murine Melanoma

The half-time of cells and molecules used in immunotherapy is limited. Scaffolds-based immunotherapy against cancer may increase the half-life of the molecules and also support the migration and activation of leukocytes in situ. For this purpose, the use of gelatin (Ge)/hyaluronic acid (HA) scaffold...

Full description

Bibliographic Details
Main Authors: Gabriela Piñón-Zárate, Beatriz Hernández-Téllez, Katia Jarquín-Yáñez, Miguel Ángel Herrera-Enríquez, América Eréndira Fuerte-Pérez, Esther Alejandra Valencia-Escamilla, Andrés Eliú Castell-Rodríguez
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Polymers
Subjects:
gelatine/hyaluronic acid scaffolds
immunomatherials
immunotherapy
melanoma
Online Access:https://www.mdpi.com/2073-4360/14/21/4608

Similar Items

Similar Items